Uterine cancer statistics

Cases

New cases of uterine cancer, 2014-2016 average, UK

Deaths

Deaths from uterine cancer, 2015-2017, UK

 

Survival

Survive uterine cancer for 10 or more years, 2010-11, England and Wales

Preventable cases

Uterine cancer cases are preventable, UK, 2015

 

  • There are around 9,300 new uterine cancer cases in the UK every year, that's 26 every day (2014-2016).
  • In females in the UK, uterine cancer is the 4th most common cancer, with around 9,500 new cases in 2016
  • Uterine cancer accounts for 5% of all new cancer cases in females in the UK (2016).
  • Uterine cancer accounts for 3% of all new cancer cases in females and males combined in the UK (2016).
  • Incidence rates for uterine cancer in the UK are highest in females aged 75 to 79 (2014-2016).
  • Since the early 1990s, uterine cancer incidence rates have increased by almost three-fifths (57%) in females in the UK.
  • Over the last decade, uterine cancer incidence rates have increased by around a fifth (19%) in females in the UK.
  • Around a fifth of uterine cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
  • Most uterine cancers occur in the endometrium.
  • Incidence rates for uterine cancer are projected to fall by 7% in the UK between 2014 and 2035, to 33 cases per 100,000 females by 2035.
  • Uterine cancer incidence in England is not associated with deprivation.
  • Uterine cancer is as common in White, Asian and Black females.
  • An estimated 70,200 women who had previously been diagnosed with uterine cancer were alive in the UK at the end of 2010.

See more in-depth uterine cancer incidence statistics

  • There are around 2,300 uterine cancer deaths in the UK every year, that's more than 6 every day (2015-2017).
  • In females in the UK, uterine cancer is the 8th most common cause of cancer death, with around 2,400 deaths in 2017.
  • Uterine cancer accounts for 3% of all cancer deaths in females in the UK (2017).
  • Uterine cancer accounts for 1% of all cancer deaths in females and males combined in the UK (2017).
  • Mortality rates for uterine cancer in the UK are highest in females aged 90+ (2015-2017).
  • Since the early 1970s, uterine cancer mortality rates have remained stable in females in the UK.
  • Over the last decade, uterine cancer mortality rates have increased by around a fifth (21%) in females in the UK.
  • Mortality rates for uterine cancer are projected to rise by 19% in the UK between 2014 and 2035, to 9 deaths per 100,000 females by 2035.
  • Uterine cancer deaths in England are more common in females living in the most deprived areas.

See more in-depth uterine cancer mortality statistics

  • Almost 8 in 10 (78%) women diagnosed with uterine cancer in England and Wales survive their disease for ten years or more (2010-11).
  • Around 8 in 10 (79%) women diagnosed with uterine cancer in England and Wales survive their disease for five years or more (2010-11).
  • 9 in 10 (90%) women diagnosed with uterine cancer in England and Wales survive their disease for one year or more (2010-11).
  • Almost 9 in 10 women in England diagnosed with uterine cancer aged 15-39 survive their disease for five years or more, compared with less than 6 in 10 women diagnosed aged 80 and over (2009-2013).
  • Uterine cancer survival is improving and has increased in the last 40 years in the UK.
  • In the 1970s, almost 6 in 10 women diagnosed with uterine cancer survived their disease beyond ten years, now it's almost 8 in 10.
  • When diagnosed at its earliest stage, 95% of women with uterine cancer will survive their disease for five years or more, compared with around 3 in 20 women when diagnosed at the latest stage.
  • Five-year relative survival for uterine cancer in women is similar to the European average in England, Wales, Scotland and Northern Ireland.

See more in-depth uterine cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 36 UK females will be diagnosed with uterine cancer in their lifetime.
  • 34% of uterine cancer cases in the UK are preventable.

See more in-depth uterine cancer risk statistics

  • 'Two-week wait' is the most common route to diagnosing uterine cancer.
  • GP referral is the route with the highest proportion of cases diagnosed at an early stage, for uterine cancer.
  • 'Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
  • Around 8 in 10 uterine cancer patients receive major surgical resection as part of their cancer treatment.
  • 21% of patients diagnosed with uterine cancer have radiotherapy as part of their primary cancer treatment.
  • 16% of patients diagnosed with uterine cancer have chemotherapy as part of their primary cancer treatment.

See more in-depth uterine cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.